Analyst Ratings for Neurocrine Biosciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 13 analysts have published their opinion on Neurocrine Biosciences (NASDAQ:NBIX) stock. The average 12-month price target for the stock is $120.92, with a high of $150.00 and a low of $96.00. The average price target has increased by 2.65% over the past month.
August 04, 2023 | 11:55 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a generally positive outlook on Neurocrine Biosciences, with an average 12-month price target of $120.92.
The average 12-month price target for Neurocrine Biosciences is $120.92, indicating a generally positive outlook from analysts. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100